Longeveron Inc. (LGVN:NASDAQ) closed at $1.61 on October 26, 2026, up 0.31% on the day. The stock trades 87.0% below its 52-week high of $12.30 and 22.5% above its 52-week low of $1.31. Longeveron Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, LGVN closed higher on 103 days (41%). Its best day was March 9, 2026 (+995.04%) and its worst was September 17, 2026 (-59.43%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 4 times.
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).
Find more stocks like LGVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.